- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Sakar Healthcare Limited — Updates, 19-12-2025: General Updates
19-12-2025 | 10:39 am
19-12-2025 | 10:39 am
Sakar's oncology unit will now manufacture Imatinib (100mg & 400mg) for Accord's EU market, the first of nine oncology products. This joint effort with Accord-Intas is expected to boost Sakar's top-line sales and capacity utilization in the coming fiscal year.
No comments yet. Be the first to comment!